BRIEF-Eleven Biotherapeutics to collaborate with Astrazeneca, National Cancer Institute
June 06, 2017 at 08:10 AM EDT
* Eleven Biotherapeutics to collaborate with Astrazeneca and National Cancer Institute on development of vicinium in combination with durvalumab
